365 related articles for article (PubMed ID: 12903804)
1. Immunotherapy in multiple myeloma: current strategies and future prospects.
Yi Q
Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
[TBL] [Abstract][Full Text] [Related]
2. Novel immunotherapies.
Yi Q
Cancer J; 2009; 15(6):502-10. PubMed ID: 20010170
[TBL] [Abstract][Full Text] [Related]
3. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
4. Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.
Bogen B; Ruffini PA; Corthay A; Fredriksen AB; Frøyland M; Lundin K; Røsjø E; Thompson K; Massaia M
Haematologica; 2006 Jul; 91(7):941-8. PubMed ID: 16818282
[TBL] [Abstract][Full Text] [Related]
5. DC in multiple myeloma immunotherapy.
Turtle CJ; Brown RD; Joshua DE; Hart DN
Cytotherapy; 2004; 6(2):128-37. PubMed ID: 15203989
[TBL] [Abstract][Full Text] [Related]
6. Active immunotherapy of multiple myeloma.
Houet L; Veelken H
Eur J Cancer; 2006 Jul; 42(11):1653-60. PubMed ID: 16797966
[TBL] [Abstract][Full Text] [Related]
7. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic vaccination as therapy for multiple myeloma.
Kwak LW; Thielemans K; Massaia M
Semin Hematol; 1999 Jan; 36(1 Suppl 3):34-7. PubMed ID: 9989488
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunotherapy for multiple myeloma.
Rosenblatt J; Avigan D
Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
[TBL] [Abstract][Full Text] [Related]
10. [The preparation of myeloma-specific T cells activated with dendritic cells loaded with nonapeptides derived from mucin protein MUC1 and catalytic subunit of telomerase hTERT].
Ocadlíková D; Kovárová L; Hájek R; Michálek J
Klin Onkol; 2008; 21(2):59-65. PubMed ID: 19102213
[TBL] [Abstract][Full Text] [Related]
11. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
[TBL] [Abstract][Full Text] [Related]
12. Peptide-based immunotherapy for multiple myeloma: current approaches.
Zhou FL; Meng S; Zhang WG; Wei YC; Cao XM; Bai GG; Wang BY
Vaccine; 2010 Aug; 28(37):5939-46. PubMed ID: 20619381
[TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
Chiriva-Internati M; Cobos E; Kast WM
Int Rev Immunol; 2007; 26(3-4):197-222. PubMed ID: 17558744
[TBL] [Abstract][Full Text] [Related]
15. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
[TBL] [Abstract][Full Text] [Related]
16. Idiotypic vaccination in B-cell malignancies.
Bianchi A; Massaia M
Mol Med Today; 1997 Oct; 3(10):435-41. PubMed ID: 9358470
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in multiple myeloma immunotherapy.
Ruffini PA; Biragyn A; Kwak LW
Biomed Pharmacother; 2002 May; 56(3):129-32. PubMed ID: 12046683
[TBL] [Abstract][Full Text] [Related]
18. The role of idiotype vaccines in the treatment of human B-cell malignancies.
Bendandi M
Expert Rev Vaccines; 2004 Apr; 3(2):163-70. PubMed ID: 15056042
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in multiple myeloma--possibility or probability?
Harrison SJ; Cook G
Br J Haematol; 2005 Aug; 130(3):344-62. PubMed ID: 16042684
[TBL] [Abstract][Full Text] [Related]
20. Current role of immunotherapy in multiple myeloma.
Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
